Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Matera

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Pulmonary Pharmacology & Therapeutics|April 22, 1999
Nitric oxide and airwaysM G Matera
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 11, 2007
Adenosine receptors: novel targets for drug development in allergic rhinitisM G Matera, R Polosa
Respiratory Medicine|August 28, 1999
Should long-acting beta 2-agonists be considered an alternative first choice option for the treatment of stable COPD?M Cazzola, M G Matera
Respiratory Medicine|March 10, 1999
Interrelationship between pharmacokinetics and pharmacodynamics in choosing the appropriate antibiotic and the dosage regimen for treating acute exacerbations of chronic bronchitisM Cazzola, M G Matera
British Journal of Pharmacology|July 8, 2008
Novel long-acting bronchodilators for COPD and asthmaM Cazzola, M G Matera
The European Respiratory Journal|September 2, 2009
Emerging inhaled bronchodilators: an updateM Cazzola, M G Matera
Trends in Pharmacological Sciences|January 19, 2000
5-HT modifiers as a potential treatment of asthmaI Cazzola, M G Matera
Pulmonary Pharmacology & Therapeutics|June 1, 1997
The use of bronchodilators in stable chronic obstructive pulmonary diseaseM Cazzola, D Spina, M G Matera
Drugs of Today (Barcelona, Spain : 1998)|March 11, 2015
Aclidinium/formoterol fixed-dose combination for the treatment of chronic obstructive pulmonary diseaseM Cazzola, L Calzetta, M G Matera
Pulmonary Pharmacology & Therapeutics|November 4, 2000
Parenteral antibiotic therapy in the treatment of lower respiratory tract infections. Strategies to minimize the development of antibiotic resistanceM Cazzola, M G Matera, P Noschese
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Pulmonary Pharmacology & Therapeutics|April 22, 1999
Nitric oxide and airwaysM G Matera
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 11, 2007
Adenosine receptors: novel targets for drug development in allergic rhinitisM G Matera, R Polosa
Respiratory Medicine|August 28, 1999
Should long-acting beta 2-agonists be considered an alternative first choice option for the treatment of stable COPD?M Cazzola, M G Matera
Respiratory Medicine|March 10, 1999
Interrelationship between pharmacokinetics and pharmacodynamics in choosing the appropriate antibiotic and the dosage regimen for treating acute exacerbations of chronic bronchitisM Cazzola, M G Matera
British Journal of Pharmacology|July 8, 2008
Novel long-acting bronchodilators for COPD and asthmaM Cazzola, M G Matera
The European Respiratory Journal|September 2, 2009
Emerging inhaled bronchodilators: an updateM Cazzola, M G Matera
Trends in Pharmacological Sciences|January 19, 2000
5-HT modifiers as a potential treatment of asthmaI Cazzola, M G Matera
Pulmonary Pharmacology & Therapeutics|June 1, 1997
The use of bronchodilators in stable chronic obstructive pulmonary diseaseM Cazzola, D Spina, M G Matera
Drugs of Today (Barcelona, Spain : 1998)|March 11, 2015
Aclidinium/formoterol fixed-dose combination for the treatment of chronic obstructive pulmonary diseaseM Cazzola, L Calzetta, M G Matera
Pulmonary Pharmacology & Therapeutics|November 4, 2000
Parenteral antibiotic therapy in the treatment of lower respiratory tract infections. Strategies to minimize the development of antibiotic resistanceM Cazzola, M G Matera, P Noschese
Pageof 12